Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-25 @ 7:17 PM
NCT ID:
NCT01703832
Population Description:
33 participants were randomized to Neurexan and 32 participants to Natural Course. All randomized participants were included in the Safety Set. One premature terminator could not be evaluated for primary efficacy, so 32 participants in the Neurexan group and 32 participants in the Natural Course group formed the Full Analysis Set for efficacy.
Study:
NCT01703832
Study Brief:
Results Section:
NCT01703832